Previous 10 | Next 10 |
home / stock / nicxf / nicxf news
Press Release Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEO More than 25 years of experience in senior business development and corporate roles, with over 6 years as Chief Business Officer of Nicox Initial focus on securing financing to complete Phase...
Press Release Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal Trial Agreement in principle for an amendment to debt agreements for outstanding bonds Streamline corporate structure to focus on the completion of ...
Attachment EN_Kowa Japan NCX470 Licensing PR_20240208_F
Attachment EN_ARVO 2024_ABSTRACTS_ 20240206_F
Attachment EN_VYZULTA 5-YearPTE_20240131_F
1 Net revenue consists of revenue from collaborations less royalty payments which corresponds to Net profit in the consolidated statements of profit or loss. 2 In the case of a merger by acquisition (fusion par absorption), merger (fusion par création d’une nouvelle socié...
Attachment EN_NCX 470 Whistler Ph3b FPFV PR_20231218_F
Attachment EN_NCX 470 IOPvsLumigan JOPT Publication PR_20231214
nicox sa Interim Consolidated statement of Comprehensive Income (1) Non-cash adjustment on NCX 4251 estimated fair value due to the Group decision to seek a partner to pursue the development in the U.S. nicox sa Interim consolidated statement of financial position ...
1 Net revenue consists of revenue from collaborations less royalty payments which corresponds to Net profit in the consolidated statements of profit or loss. 2 In the case of a merger by acquisition (fusion par absorption), merger (fusion par création d’une nouvelle sociét...
News, Short Squeeze, Breakout and More Instantly...
Nicox SA Company Name:
NICXF Stock Symbol:
OTCMKTS Market:
Attachment EN_DenaliLastUSPatient_PR_FINAL
Attachment EN_Nicox Conferences 2024_FINAL
1 Net revenue consists of revenue from collaborations less royalty payments 2 Intra-ocular pressure Attachment EN_Q22024Results_PR_FINAL